Copyright
©The Author(s) 2024.
World J Orthop. Nov 18, 2024; 15(11): 1056-1074
Published online Nov 18, 2024. doi: 10.5312/wjo.v15.i11.1056
Published online Nov 18, 2024. doi: 10.5312/wjo.v15.i11.1056
Figure 3 Right hind leg pictures of the tested groups.
A-C: Right hind legs normal rats at the 4th week (A), 5th week (B), and 6th week (C); D-F: Osteoar thritic rats in the 4th week (D), 5th week (E), and 6th week (F) showed swelling and redness as external signs of inflammation; G-O: Osteoarthritic rats treated with bone marrow mesenchymal stem cells (BMMSCs) (G-I), hyaluronic acid (HA), (J-L) and BMMSCs + HA (M-O) exhibited marked improvements in these morphological signs (in the 4th, 5th, and 6th weeks, respectively).
- Citation: Hagag UI, Halfaya FM, Al-Muzafar HM, Al-Jameel SS, Amin KA, Abou El-Kheir W, Mahdi EA, Hassan GANR, Ahmed OM. Impacts of mesenchymal stem cells and hyaluronic acid on inflammatory indicators and antioxidant defense in experimental ankle osteoarthritis. World J Orthop 2024; 15(11): 1056-1074
- URL: https://www.wjgnet.com/2218-5836/full/v15/i11/1056.htm
- DOI: https://dx.doi.org/10.5312/wjo.v15.i11.1056